首页> 外文期刊>Singapore medical journal >Contemporary management and outcomes of infective tunnelled haemodialysis catheter-related right atrial thrombi: a case series and literature review
【24h】

Contemporary management and outcomes of infective tunnelled haemodialysis catheter-related right atrial thrombi: a case series and literature review

机译:感染性隧道血液透析导管相关右心房血栓的当代管理和结果:案例系列与文献综述

获取原文
       

摘要

INTRODUCTION Infective haemodialysis catheter-related right atrial thrombus (CRAT) is a complication of tunnelled catheter use. Management recommendations are based mainly on published case series prior to 2011. We report our institution’s recent experience in managing infective haemodialysis CRAT and correlate treatment with outcomes. METHODS We conducted a retrospective analysis of haemodialysis CRAT cases diagnosed on transthoracic echocardiography between 1 January 2011 and 31 December 2017. Clinical outcomes, including mortality at 180 days post diagnosis and thrombus resolution, were traced from electronic medical records. RESULTS There were 14 cases identified. The median age was 59 (range 47–88) years and 11 (78.6%) were male. Sepsis was the most common reason for hospitalisation (71.4%). Blood cultures identified Staphylococcus aureus in seven cases, of which two were methicillin-resistant. Three had coagulase-negative Staphylococcus . All cases received antibiotics with infectious disease physician input. Seven were treated with catheter removal alone, of which three died within 180 days. Both cases treated with catheter removal plus anticoagulation survived at 180 days. Of the two cases who had anticoagulation without catheter removal, one died within 180 days and the other did not have thrombus resolution. Three underwent surgical thrombus removal, of which two died postoperatively and the last required repeated operations and prolonged hospitalisation. Mortality at 180 days post diagnosis was 42.9%. CONCLUSION Catheter removal and anticoagulation are modestly effective. Surgery is associated with poor outcomes. Despite contemporary management, infective haemodialysis CRAT still results in high mortality. Prospective studies are needed to identify the optimal management.
机译:引言感染性血液透析导管相关的右心房血栓(CRAT)是隧道导管使用的并发症。管理层建议主要基于2011年之前发表的案例系列。我们报告了我们的机构最近在管理感染性血液透析CRAT和与结果进行治疗方面的经验。方法采用2011年1月1日至12月31日诊断患者对血液透析CRAT病例进行了回顾图分析。临床结果,包括诊断后180天的死亡率,包括死亡率和血栓解决,从电子病历中追踪。结果确定了14例。中位年龄为59(范围47-88)年,11名(78.6%)是男性。败血症是住院治疗最常见的原因(71.4%)。血液培养物在7例中鉴定了金黄色葡萄球菌,其中两个是耐甲氧西林。三个有凝固酶阴性葡萄球菌。所有病例均接受抗生素具有传染病医师投入。单独用导管除去七,其中三天在180天内死亡。两种患者治疗导管去除加抗刺激在180天内存活。在没有导管去除的两种患者中,在180天内死亡,另一个没有血栓分辨率。三次接受手术血栓去除,其中两者术后死于术后和最后一次需要的重复操作和长期住院治疗。诊断后180天的死亡率为42.9%。结论导管去除和抗凝型在适度有效。手术与差的结果有关。尽管现代管理,感染性血液透析CRAT仍然导致高死亡率。需要预期研究来确定最佳管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号